FindTrial
Sign In

Prediction of Ovarian Response in GnRH Antagonist Treatment of Controlled Ovarian Stimulation (COS) Using Beckman Coulter Anti-Mullerian Hormone (AMH) Assay

The role of AMH in prediction of Ovarian Response in GnRH Antagonist Treatment of Controlled Ovarian Stimulation (COS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-16009002
Enrollment
Unknown
Registered
2016-08-10
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Case series:Non

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Women aged 20-45 years; 2) BMI<30; 3) Regular menstrual cycle (25-35 days/cycle) in the past 12 months; 4) A transvaginal ultrasound showing adequate visualization of both ovaries without evidence of abnormality.

Exclusion criteria

Exclusion criteria: 1) Fallopian tube abnormality; 2) Poly cystic ovarian syndrome (PCOS), Endocrine system diseases, metabolic syndromes, pituitary diseases, history of uterus or ovary surgery; 3) Pregnancy history within 6 months; 4) Smoking; 5) Use of contraceptive or other drugs that may influence reproductive hormones within 2 months; 6) Previous IVF treatment.

Design outcomes

Primary

MeasureTime frame
ovarian response;—

Secondary

MeasureTime frame
duration of stimulation;total cumulative dose of rhFSH;# of suitable embryos for transfer and cryopreservation.;—

Countries

China

Contacts

Public ContactRong Li

Peking University Third Hospital

roseli001@sina.com+86 13701085402

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026